FDA: J&J delayed reporting insulin pump problems The FDA says inspectors found Animas never reported or delayed reporting on patients hospitalized with dangerously high blood sugar, respiratory failure and coma, and a life-threatening complication called diabetic ketoacidosis.
Post new comment